Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × High-Intensity Interval Training × Clear all

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Motor Activity 1 Hematologic Neoplasms 1

Interventions

Oxaliplatin 44 Fluorouracil 41 Leucovorin 38 Capecitabine 35 Bevacizumab 27 Irinotecan 26 Radiotherapy 22 Cetuximab 20 Panitumumab 12 Radiation 11 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 7 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Chemotherapy, Adjuvant 5 aflibercept 4 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 XELOX 3 Neoadjuvant Therapy 3 Fluorodeoxyglucose F18 3 Erlotinib Hydrochloride 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 veliparib 2 trifluridine tipiracil drug combination 2 regorafenib 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡